1-3 of 3
Jonathan R.A. de Wilde
Close
Sort by
Journal Articles

The Pyruvate Kinase (PK) Activator AG-946 Improves PK Properties and Red Blood Cell (RBC) Characteristics upon Ex Vivo treatment of RBCs from Patients with Myelodysplastic Syndromes

Jonathan R.A. De Wilde, Titine J.J. Ruiter, Brigitte A. van Oirschot, Judith J.M. Jans, Lenny Dang, Megan Wind-Rotolo, Noortje Thielen, Wouter W. van Solinge, Anna van Rhenen, Richard van Wijk, Minke A.E. Rab
Journal: Blood
Blood (2023) 142 (Supplement 1): 3222.
https://doi.org/10.1182/blood-2023-185772
Published: 2023
Journal Articles

Novel Biomarkers for Assessing Clinical Severity in Hereditary Spherocytosis - Application of Routine and Advanced Diagnostic Tests

Jonathan R.A. De Wilde, Maryse E. Boesveld, Annelies J. van Vuren, Wouter W. van Solinge, Eduard J. Van Beers, Marije Bartels, Esmé Waanders, Minke A.E. Rab, Richard van Wijk
Journal: Blood
Blood (2023) 142 (Supplement 1): 2453.
https://doi.org/10.1182/blood-2023-189034
Published: 2023
Journal Articles

An Endogenous Metabolic Modulator Composition Improves Hydration Status and Decreases Adhesion Properties of Red Blood Cells from Patients with Sickle Cell Disease

Myrthe J. van Dijk, Marissa J.M. Traets, Brigitte A. van Oirschot, Jonathan R.A. de Wilde, Jennifer Bos, Wouter W. van Solinge, Margaret J. Koziel, Revati Wani, Eduard J. van Beers, Richard van Wijk, Minke A.E. Rab
Journal: Blood
Blood (2022) 140 (Supplement 1): 8235–8237.
https://doi.org/10.1182/blood-2022-166177
Published: 2022